ROIV

Roivant Sciences Ltd.

11.58 USD
+0.22 (+1.94%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Roivant Sciences Ltd. stock is up 11.35% since 30 days ago. The next earnings date is Jun 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 9 CALLs, 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
02 Jan 17:41 16 Jan, 2026 7.50 CALL 50 7
05 Jan 18:28 19 Jan, 2024 10.00 CALL 744 22144
08 Jan 16:54 19 Jan, 2024 10.00 CALL 800 22060
09 Jan 15:23 19 Jan, 2024 11.00 CALL 1200 12987
01 Feb 15:23 15 Mar, 2024 10.00 CALL 338 2343
01 Feb 15:23 15 Mar, 2024 10.00 CALL 481 2343
08 Feb 20:11 17 May, 2024 10.00 CALL 400 1549
09 Feb 15:35 17 May, 2024 9.00 CALL 255 158
15 Feb 14:30 16 Feb, 2024 9.00 CALL 100 175
20 Feb 16:02 15 Mar, 2024 10.00 PUT 7500 1460

About Roivant Sciences Ltd.

Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company that researches and develops medicines. The company was founded in 2014 and is based in London, the United Kingdom.

  • Wolfe Research
    Thu Feb 15, 06:40
    buy
    initial
  • HC Wainwright & Co.
    Wed Feb 14, 11:45
    buy
    confirm